Perspective Therapeutics, Inc. Stock
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -1.25% | +5.33% | +293.03% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 927M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -56M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-17.6
x | P/E ratio 2025 * |
-13.7
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.6% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | -1.25% | ||
1 week | +5.33% | ||
Current month | +32.77% | ||
1 month | +27.42% | ||
3 months | +152.64% | ||
6 months | +510.98% | ||
Current year | +293.03% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 51 | 23-02-02 |
Mark Austin
DFI | Director of Finance/CFO | 37 | - |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 23-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 23-05-31 |
Lori Woods
CHM | Chairman | 62 | 23-02-02 |
Director/Board Member | 58 | 23-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.58 | -1.25% | 4,686,178 |
24-04-25 | 1.6 | -5.33% | 4,568,471 |
24-04-24 | 1.69 | -0.59% | 6,378,397 |
24-04-23 | 1.7 | +11.11% | 6,552,861 |
24-04-22 | 1.53 | +2.00% | 5,517,631 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+293.03% | 927M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- CATX Stock